TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Amur Minerals ( (GB:CRTX) ) is now available.
CRISM Therapeutics Corporation has announced its Annual General Meeting (AGM) scheduled for August 26, 2025, where a resolution for a new Enterprise Management Incentives (EMI) Option Plan will be discussed. The EMI Option Plan aims to recruit, retain, and incentivize key talent by offering eligible employees the chance to acquire shares at a fixed price, aligning employee and shareholder interests. This plan is also designed to include non-tax favored options for advisors and directors, with options vesting over two years and expiring after ten years. The plan’s introduction is seen as a strategic move to strengthen CRISM’s market position by attracting top talent and aligning their interests with the company’s long-term goals.
More about Amur Minerals
CRISM Therapeutics Corporation specializes in innovative drug delivery technology aimed at enhancing the clinical performance of cancer treatments for solid tumors. Their lead product, ChemoSeed, allows for the direct implantation of chemotherapy drugs into tumors or resection margins, improving drug delivery and efficacy, particularly in challenging cases like glioblastoma.
Average Trading Volume: 65,824
Technical Sentiment Signal: Sell
Current Market Cap: £4.3M
See more data about CRTX stock on TipRanks’ Stock Analysis page.